Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 7/2019

01-07-2019 | Gentamicin | Otology

Therapeutic strategies in the treatment of Menière's disease: the Italian experience

Authors: Nicola Quaranta, P. Picciotti, G. Porro, B. Sterlicchio, G. Danesi, P. Petrone, Giacinto Asprella Libonati

Published in: European Archives of Oto-Rhino-Laryngology | Issue 7/2019

Login to get access

Abstract

Purpose

Ménière's disease (MD) is an inner ear disorder of unknown etiology, whose pathological substrate is the endolymphatic hydrops. Different treatments have been proposed; however, evidence of their effectiveness is lacking. The aim of this study was to evaluate by a questionnaire which medical and surgical treatments are used in Italy for the treatment of MD and to compare them with those proposed in other countries.

Methods

An electronic questionnaire of 40 questions was formulated and sent to Italian otolaryngologist (ENT) divided into two groups: Group 1 (“generalists” 60.8%) and Group 2 (“neurotologist- NO” 39.2%).

Results

One hundred and twenty five ENT replied. Treatment of the acute phase, apart from symptomatics, was based on diuretics that are prescribed by 83.5% of respondents, steroids, prescribed by 66.7%, and vasodilators, prescribed by 22%. In the intercritical phase, 87.2% of respondents recommended low-salt diet, 78.4% of respondents prescribed betahistine, and 52.8% diuretics. Statistical analysis did not show correlation neither with the declared specialization nor with the number of patients treated. In case of failure of medical treatment, IT gentamicin was suggested by 48.8% of the respondents and IT steroids by 40.8%. Statistical analysis showed that generalists prefer IT steroids and NO IT gentamicin (p 0.019). In case of failure of both medical treatment and IT treatment, vestibular neurectomy was indicated by 58.4% of the respondents, 6.4% indicated endolymphatic sac surgery, and 2.4% surgical labyrinthectomy.

Conclusion

In Italy, the treatment of MD stand on a gradual approach that starts from the dietary-behavioral changes and a pharmacological therapy based on betahistine. In refractory cases, IT treatment initially with steroids and, therefore, with gentamicin allows the control in vertigo in the majority of cases. In case of failure of IT treatment, VNS is the surgery of choice.
Literature
1.
go back to reference Committee on Hearing and Equilibrium (1995) Guidelines for the diagnosis and evaluation of therapy in Ménière's disease. Otolaryngol Head Neck Surg 113:181–185CrossRef Committee on Hearing and Equilibrium (1995) Guidelines for the diagnosis and evaluation of therapy in Ménière's disease. Otolaryngol Head Neck Surg 113:181–185CrossRef
2.
go back to reference Tyrrell JS, Whinney DJ, Ukoumunne OC, Fleming LE, Osborne NJ (2014) Prevalence, associated factors, and comorbid conditions for Menière’s disease. Ear Hear 35:e162–e169CrossRef Tyrrell JS, Whinney DJ, Ukoumunne OC, Fleming LE, Osborne NJ (2014) Prevalence, associated factors, and comorbid conditions for Menière’s disease. Ear Hear 35:e162–e169CrossRef
3.
go back to reference Harris JP, Alexander TH (2010) Current-day prevalence of Menière’s syndrome. Audiol Neurootol 15:318–322CrossRef Harris JP, Alexander TH (2010) Current-day prevalence of Menière’s syndrome. Audiol Neurootol 15:318–322CrossRef
4.
go back to reference Celestino D, Ralli G (1991) Incidence of Ménière’s disease in Italy. Am J Otol 12(2):135–138PubMed Celestino D, Ralli G (1991) Incidence of Ménière’s disease in Italy. Am J Otol 12(2):135–138PubMed
5.
go back to reference Minor LB, Schessel DA, Carey JP (2004) Ménière’s disease. Curr Opin Neurol 17(1):9–16CrossRef Minor LB, Schessel DA, Carey JP (2004) Ménière’s disease. Curr Opin Neurol 17(1):9–16CrossRef
6.
go back to reference Morrison AW, Jhonson KJ (2002) Genetics (molecular biology) and Ménière's disease. Otolaryngol Clin N Am 35(3):497–516CrossRef Morrison AW, Jhonson KJ (2002) Genetics (molecular biology) and Ménière's disease. Otolaryngol Clin N Am 35(3):497–516CrossRef
7.
go back to reference House JW, Doherty JK, Fisher LM, Derebery MJ, Berliner KI (2006) Menière’s disease: prevalence of contralateral ear involvement. Otol Neurotol 27:355–361CrossRef House JW, Doherty JK, Fisher LM, Derebery MJ, Berliner KI (2006) Menière’s disease: prevalence of contralateral ear involvement. Otol Neurotol 27:355–361CrossRef
8.
go back to reference Huppert D, Strupp M, Brandt T (2010) Long-term course of Menière’s disease revisited. Acta Otolaryngol 130:644–651CrossRef Huppert D, Strupp M, Brandt T (2010) Long-term course of Menière’s disease revisited. Acta Otolaryngol 130:644–651CrossRef
9.
go back to reference Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, Newman-Toker DE, Strupp M, Suzuki M, Trabalzini F, Bisdorff A, Classification Committee of the Barany Society; Japan Society for Equilibrium Research; European Academy of Otology, and Neurotology (EAONO); Equilibrium Committee of the American Academy of Otolaryngology-Head, and Neck Surgery (AAO-HNS); Korean Balance Society (2015) Diagnostic criteria for Menière's disease. J Vestib Res 25(1):1–7CrossRef Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, Newman-Toker DE, Strupp M, Suzuki M, Trabalzini F, Bisdorff A, Classification Committee of the Barany Society; Japan Society for Equilibrium Research; European Academy of Otology, and Neurotology (EAONO); Equilibrium Committee of the American Academy of Otolaryngology-Head, and Neck Surgery (AAO-HNS); Korean Balance Society (2015) Diagnostic criteria for Menière's disease. J Vestib Res 25(1):1–7CrossRef
10.
go back to reference Goebel JA (2016) 2015 equilibrium Committee amendement to the 1995’s AAO-HNS guidelines for the definition of Menière’s disease. Otolaryngol Head Neck Surg 154(3):403–404CrossRef Goebel JA (2016) 2015 equilibrium Committee amendement to the 1995’s AAO-HNS guidelines for the definition of Menière’s disease. Otolaryngol Head Neck Surg 154(3):403–404CrossRef
11.
go back to reference Nakashima T, Pyykkö I, Arroll MA, Casselbrant ML, Foster CA, Manzoor NF, Megerian CA, Naganawa S, Young YH (2016) Menière's disease. Nat Rev Dis Primers 2:16028CrossRef Nakashima T, Pyykkö I, Arroll MA, Casselbrant ML, Foster CA, Manzoor NF, Megerian CA, Naganawa S, Young YH (2016) Menière's disease. Nat Rev Dis Primers 2:16028CrossRef
12.
go back to reference Nevoux J, Barbara M, Dornhoffer J, Gibson W, Kitahara T, Darrouzet V (2018) International consensus (ICON) on treatment of Menière’s disease. Euro Ann Otorhinolaryngol Head Neck Dis 135:S29–S32CrossRef Nevoux J, Barbara M, Dornhoffer J, Gibson W, Kitahara T, Darrouzet V (2018) International consensus (ICON) on treatment of Menière’s disease. Euro Ann Otorhinolaryngol Head Neck Dis 135:S29–S32CrossRef
13.
go back to reference Smith WK, Sankar V, Pfleiderer AG (2005) A national survey amongst UK otolaryngologists regarding the treatment of Menière’s disease. J Laryngol Otol 119:102–105CrossRef Smith WK, Sankar V, Pfleiderer AG (2005) A national survey amongst UK otolaryngologists regarding the treatment of Menière’s disease. J Laryngol Otol 119:102–105CrossRef
14.
go back to reference Clyde JW, Oberman BS, Isildak H (2017) Current Management Practices in Menière's Disease. Otol Neurotol 38:159–167CrossRef Clyde JW, Oberman BS, Isildak H (2017) Current Management Practices in Menière's Disease. Otol Neurotol 38:159–167CrossRef
15.
go back to reference Klockhoff I, Lindblom U (1966) Endolymphatic hydrops revealed by glycerol test preliminary report. Acta Otolaryngol. 61(5):459–462CrossRef Klockhoff I, Lindblom U (1966) Endolymphatic hydrops revealed by glycerol test preliminary report. Acta Otolaryngol. 61(5):459–462CrossRef
16.
go back to reference Angelborg C, Klockhoff I, Larsen HC, Stahle J (1982) Hyperosmotic solutions and hearing Menière's disease. Am J Otol 3(3):200–202PubMed Angelborg C, Klockhoff I, Larsen HC, Stahle J (1982) Hyperosmotic solutions and hearing Menière's disease. Am J Otol 3(3):200–202PubMed
17.
go back to reference Rosenbaum A, Winter M (2018) Are diuretics effective for Ménière`s disease? Medwave 18(2):e7188CrossRef Rosenbaum A, Winter M (2018) Are diuretics effective for Ménière`s disease? Medwave 18(2):e7188CrossRef
18.
go back to reference Crowson MG, Patki A, Tucci DL (2016) A systematic review of diuretics in the medical management of Ménière's disease. Otolaryngol Head Neck Surg 154(5):824–834CrossRef Crowson MG, Patki A, Tucci DL (2016) A systematic review of diuretics in the medical management of Ménière's disease. Otolaryngol Head Neck Surg 154(5):824–834CrossRef
19.
go back to reference Adrion C, Fischer CS, Wagner J, Gürkov R, Mansmann U, Strupp M, BEMED Study Group (2016) Efficacy and safety of betahistine treatment in patients with Menière's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ 352:6816CrossRef Adrion C, Fischer CS, Wagner J, Gürkov R, Mansmann U, Strupp M, BEMED Study Group (2016) Efficacy and safety of betahistine treatment in patients with Menière's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ 352:6816CrossRef
20.
go back to reference Casani AP, Navari E, Guidetti G, Lacour M (2018) Good clinical approach: Delphi Consensus for the use of Betahistine in Menière's disease. Int J Otolaryngol 2018:5359208CrossRef Casani AP, Navari E, Guidetti G, Lacour M (2018) Good clinical approach: Delphi Consensus for the use of Betahistine in Menière's disease. Int J Otolaryngol 2018:5359208CrossRef
21.
go back to reference Teggi R, Gatti O, Sykopetrites V, Quaglieri S, Benazzo M, Bussi M (2014) Association of cinnarizine and betahistine in prophylactic therapy for Ménière's disease with and without migraine. Acta Otorhinolaryngol Ital 34(5):349–353PubMedPubMedCentral Teggi R, Gatti O, Sykopetrites V, Quaglieri S, Benazzo M, Bussi M (2014) Association of cinnarizine and betahistine in prophylactic therapy for Ménière's disease with and without migraine. Acta Otorhinolaryngol Ital 34(5):349–353PubMedPubMedCentral
22.
go back to reference Albera R, Ciuffolotti R, Di Cicco M, De Benedittis G, Grazioli I, Melzi G, Mira E, Pallestrini E, Passali D, Serra A, Vicini C (2003) Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Otolaryngol 123(5):588–593CrossRef Albera R, Ciuffolotti R, Di Cicco M, De Benedittis G, Grazioli I, Melzi G, Mira E, Pallestrini E, Passali D, Serra A, Vicini C (2003) Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Otolaryngol 123(5):588–593CrossRef
23.
go back to reference Fraysse B, Bebear JP, Dubreuil C, Berges C, Dauman R (1991) Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière's disease. Acta Otolaryngol Suppl 490:1–10CrossRef Fraysse B, Bebear JP, Dubreuil C, Berges C, Dauman R (1991) Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière's disease. Acta Otolaryngol Suppl 490:1–10CrossRef
24.
go back to reference Novotný M, Kostrica R (2002) Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study. Int Tinnitus J 8(2):115–123PubMed Novotný M, Kostrica R (2002) Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study. Int Tinnitus J 8(2):115–123PubMed
25.
go back to reference Itoh A, Sakata E (1991) Treatment of vestibular disorders. Acta Otolaryngol Suppl 481:617–623CrossRef Itoh A, Sakata E (1991) Treatment of vestibular disorders. Acta Otolaryngol Suppl 481:617–623CrossRef
26.
go back to reference Patel M (2017) Intratympanic corticosteroids in Menière’s disease: a mini-review. J Otol 12:117–124CrossRef Patel M (2017) Intratympanic corticosteroids in Menière’s disease: a mini-review. J Otol 12:117–124CrossRef
27.
go back to reference Lange G (1977) The intratympanic treatment of Menière's disease with ototoxic antibiotics A follow-up study of 55 cases (author's transl). Laryngol Rhinol Otol (Stuttg) 56(5):409–414 Lange G (1977) The intratympanic treatment of Menière's disease with ototoxic antibiotics A follow-up study of 55 cases (author's transl). Laryngol Rhinol Otol (Stuttg) 56(5):409–414
28.
go back to reference Syed MI, Ilan O, Nassar J, Rutka JA (2015) Intratympanic therapy in Menière's syndrome or disease: up to date evidence for clinical practice. Clin Otolaryngol 40(6):682–690CrossRef Syed MI, Ilan O, Nassar J, Rutka JA (2015) Intratympanic therapy in Menière's syndrome or disease: up to date evidence for clinical practice. Clin Otolaryngol 40(6):682–690CrossRef
29.
go back to reference Quaranta A, Scaringi A, Aloidi A, Quaranta N, Salonna I (2001) Intratympanic therapy for Ménière's disease: effect of administration of low concentration of gentamicin. Acta Otolaryngol 121(3):387–392CrossRef Quaranta A, Scaringi A, Aloidi A, Quaranta N, Salonna I (2001) Intratympanic therapy for Ménière's disease: effect of administration of low concentration of gentamicin. Acta Otolaryngol 121(3):387–392CrossRef
30.
go back to reference Chia SH, Gamst AC, Anderson JP, Harris JP (2004) Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis. Otol Neurotol 25(4):544–552CrossRef Chia SH, Gamst AC, Anderson JP, Harris JP (2004) Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis. Otol Neurotol 25(4):544–552CrossRef
32.
go back to reference Sood AJ, Lambert PR, Nguyen SA, Meyer TA (2014) Endolymphatic sac surgery for Ménière's disease: a systematic review and meta-analysis. Otol Neurotol 35(6):1033–1045CrossRef Sood AJ, Lambert PR, Nguyen SA, Meyer TA (2014) Endolymphatic sac surgery for Ménière's disease: a systematic review and meta-analysis. Otol Neurotol 35(6):1033–1045CrossRef
33.
go back to reference Quaranta A, Marini F, Sallustio V (1998) Long-term outcome of Ménière's disease: endolymphatic mastoid shunt versus natural history. Audiol Neurootol 3(1):54–60CrossRef Quaranta A, Marini F, Sallustio V (1998) Long-term outcome of Ménière's disease: endolymphatic mastoid shunt versus natural history. Audiol Neurootol 3(1):54–60CrossRef
34.
go back to reference Hillman TA, Chen DA, Arriaga MA (2004) Vestibular nerve section versus intratympanic gentamicin for Menière's disease. Laryngoscope 114(2):216–222CrossRef Hillman TA, Chen DA, Arriaga MA (2004) Vestibular nerve section versus intratympanic gentamicin for Menière's disease. Laryngoscope 114(2):216–222CrossRef
Metadata
Title
Therapeutic strategies in the treatment of Menière's disease: the Italian experience
Authors
Nicola Quaranta
P. Picciotti
G. Porro
B. Sterlicchio
G. Danesi
P. Petrone
Giacinto Asprella Libonati
Publication date
01-07-2019
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 7/2019
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-019-05423-7

Other articles of this Issue 7/2019

European Archives of Oto-Rhino-Laryngology 7/2019 Go to the issue